158 related articles for article (PubMed ID: 11034811)
21. Low tumour cell proliferation at the invasive margin is associated with a poor prognosis in Dukes' stage B colorectal cancers.
Palmqvist R; Sellberg P; Oberg A; Tavelin B; Rutegård JN; Stenling R
Br J Cancer; 1999 Feb; 79(3-4):577-81. PubMed ID: 10027333
[TBL] [Abstract][Full Text] [Related]
22. Human neutrophil peptides 1, 2 and 3 are biochemical markers for metastatic colorectal cancer.
Albrethsen J; Møller CH; Olsen J; Raskov H; Gammeltoft S
Eur J Cancer; 2006 Nov; 42(17):3057-64. PubMed ID: 17015013
[TBL] [Abstract][Full Text] [Related]
23. Cyclooxygenase-2 expression in primary human colorectal cancers and bone marrow micrometastases.
Sheehan KM; Cahill RA; McGreal G; Steele C; Byrne MF; Kirwan WO; Kay EW; Fitzgerald DJ; Redmond HP; Murray FE
Dig Liver Dis; 2004 Jun; 36(6):392-7. PubMed ID: 15248379
[TBL] [Abstract][Full Text] [Related]
24. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
[TBL] [Abstract][Full Text] [Related]
25. Gene-expression profiling predicts recurrence in Dukes' C colorectal cancer.
Arango D; Laiho P; Kokko A; Alhopuro P; Sammalkorpi H; Salovaara R; Nicorici D; Hautaniemi S; Alazzouzi H; Mecklin JP; Järvinen H; Hemminki A; Astola J; Schwartz S; Aaltonen LA
Gastroenterology; 2005 Sep; 129(3):874-84. PubMed ID: 16143127
[TBL] [Abstract][Full Text] [Related]
26. The impact of surgeon and pathologist on lymph node retrieval in colorectal cancer and its impact on survival for patients with Dukes' stage B disease.
Evans MD; Barton K; Rees A; Stamatakis JD; Karandikar SS
Colorectal Dis; 2008 Feb; 10(2):157-64. PubMed ID: 17477849
[TBL] [Abstract][Full Text] [Related]
27. Gene expression profiles and molecular markers to predict recurrence of Dukes' B colon cancer.
Wang Y; Jatkoe T; Zhang Y; Mutch MG; Talantov D; Jiang J; McLeod HL; Atkins D
J Clin Oncol; 2004 May; 22(9):1564-71. PubMed ID: 15051756
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical characterization of the innervation of human colonic mesenteric and submucosal blood vessels.
De Fontgalland D; Wattchow DA; Costa M; Brookes SJ
Neurogastroenterol Motil; 2008 Nov; 20(11):1212-26. PubMed ID: 18643894
[TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical dihydropyrimidine dehydrogenase expression is a good prognostic indicator for patients with Dukes' C colorectal cancer.
Oi K; Makino M; Ozaki M; Takemoto H; Yamane N; Nakamura S; Ikeguchi M; Kaibara N
Anticancer Res; 2004; 24(1):273-9. PubMed ID: 15015608
[TBL] [Abstract][Full Text] [Related]
30. Radical consequence in the sexuality of male patients operated for colorectal carcinoma.
Koukouras D; Spiliotis J; Scopa CD; Dragotis K; Kalfarentzos F; Tzoracoleftherakis E; Androulakis J
Eur J Surg Oncol; 1991 Jun; 17(3):285-8. PubMed ID: 2044782
[TBL] [Abstract][Full Text] [Related]
31. Pre-operative immunoprophylaxis with interleukin-2 may improve prognosis in radical surgery for colorectal cancer stage B-C.
Brivio F; Fumagalli L; Lissoni P; Nardone A; Nespoli L; Fattori L; Denova M; Chiarelli M; Nespoli A
Anticancer Res; 2006; 26(1B):599-603. PubMed ID: 16739327
[TBL] [Abstract][Full Text] [Related]
32. Infiltration of mononuclear inflammatory cells into primary colorectal carcinomas: an immunohistological analysis.
Håkansson L; Adell G; Boeryd B; Sjögren F; Sjödahl R
Br J Cancer; 1997; 75(3):374-80. PubMed ID: 9020482
[TBL] [Abstract][Full Text] [Related]
33. Clinical and biological significance of angiogenesis and lymphangiogenesis in colorectal cancer.
Gao J; Knutsen A; Arbman G; Carstensen J; Frånlund B; Sun XF
Dig Liver Dis; 2009 Feb; 41(2):116-22. PubMed ID: 19038587
[TBL] [Abstract][Full Text] [Related]
34. Low levels of insulin-like growth factor type 1 receptor expression at cancer cell membrane predict liver metastasis in Dukes' C human colorectal cancers.
Nakamura M; Miyamoto S; Maeda H; Zhang SC; Sangai T; Ishii G; Hasebe T; Endoh Y; Saito N; Asaka M; Ochiai A
Clin Cancer Res; 2004 Dec; 10(24):8434-41. PubMed ID: 15623623
[TBL] [Abstract][Full Text] [Related]
35. Blood vessels in liver metastases from both sarcoma and carcinoma lack perivascular innervation and smooth muscle cells.
Ashraf S; Loizidou M; Crowe R; Turmaine M; Taylor I; Burnstock G
Clin Exp Metastasis; 1997 Sep; 15(5):484-98. PubMed ID: 9247251
[TBL] [Abstract][Full Text] [Related]
36. Characterization of tumour-infiltrating lymphocytes and apoptosis in colitis-associated neoplasia: comparison with sporadic colorectal cancer.
Michael-Robinson JM; Pandeya N; Walsh MD; Biemer-Huttmann AE; Eri RD; Buttenshaw RL; Lincoln D; Clouston AD; Jass JR; Radford-Smith GL
J Pathol; 2006 Feb; 208(3):381-7. PubMed ID: 16315333
[TBL] [Abstract][Full Text] [Related]
37. Plasma concentration of selected neuropeptides in patients suffering from psoriasis.
Reich A; Orda A; Wiśnicka B; Szepietowski JC
Exp Dermatol; 2007 May; 16(5):421-8. PubMed ID: 17437485
[TBL] [Abstract][Full Text] [Related]
38. Selection criteria for high risk and low risk groups of recurrence and metastasis in patients with primary colorectal cancer.
Mukai M; Sato S; Nishida T; Komatsu N; Shiba K; Nakasaki H; Makuuchi H
Oncol Rep; 2003; 10(6):1753-8. PubMed ID: 14534691
[TBL] [Abstract][Full Text] [Related]
39. Effects of the neuropeptides substance P, calcitonin gene-related peptide, vasoactive intestinal polypeptide and galanin on the production of nerve growth factor and inflammatory cytokines in cultured human keratinocytes.
Dallos A; Kiss M; Polyánka H; Dobozy A; Kemény L; Husz S
Neuropeptides; 2006 Aug; 40(4):251-63. PubMed ID: 16904178
[TBL] [Abstract][Full Text] [Related]
40. A Dukes/Jass combination--is it more discriminating?
Haslam AC; Pearson JM; Bisset DL; Michie HR; Hobbiss JH
Colorectal Dis; 2006 Jun; 8(5):418-22. PubMed ID: 16684086
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
